Dr Santerre appointed Baxter Chair of Health Technology and Commercialization

Dr Paul Santerre has been appointed the Baxter Chair of Health Technology and Commercialization, created through a $2.5 million -investment by the Baxter Corporation to the University Health Network to drive entrepreneurship and commercialization initiatives at both the University Health Network and the University of Toronto. Read more about his appointment here.

Santerre lab member Jeremy Antonyshyn presents his research at the 15th Annual Meeting of the International Federation for Adipose Therapeutics and Science

Supported by an IBBME Wildcat Voyageur Scholarship, PhD candidate Jeremy Antonyshyn attends the 15th Annual Meeting of the International Federation for Adipose Therapeutics and Science in Miami, Florida to present his research on the endothelial plasticity of adipose-derived mesenchymal stem cells.